Mercer Global Advisors
MANE

Mercer Global Advisors’s Veradermics Inc MANE Stock Holding History

Mercer Global Advisors’s Portfolio MANE Stock Details MANE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$246 Buy
+2
New +$187 ﹤0.01% 5910

Other funds holding MANE

SOCM
SR One Capital Management Wayne, Pennsylvania $1.04B AUM 262.99% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Mercer Global Advisors's MANE Position: Q2 2026 in Review

Mercer Global Advisors opened a new position in Veradermics Inc (MANE) in Q2 2026: 2 shares worth $246. The stake represents ﹤0.01% of the portfolio and ranks #5910 among its holdings.

93 funds tracked by Wall St. Rank hold MANE as of Q2 2026.

  • Mercer Global Advisors held 2 shares of Veradermics Inc worth $246 as of Q2 2026.
  • Veradermics Inc was a new Mercer Global Advisors position in Q2 2026.
  • Veradermics Inc made up ﹤0.01% of Mercer Global Advisors's portfolio in Q2 2026, its #5910 holding.
  • 93 funds tracked by Wall St. Rank held Veradermics Inc as of Q2 2026.

Based on Mercer Global Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.